Rettig Eleni M, Talbot C Conover, Sausen Mark, Jones Sian, Bishop Justin A, Wood Laura D, Tokheim Collin, Niknafs Noushin, Karchin Rachel, Fertig Elana J, Wheelan Sarah J, Marchionni Luigi, Considine Michael, Ling Shizhang, Fakhry Carole, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Ha Patrick K, Agrawal Nishant
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Institute for Basic Biomedical Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Cancer Prev Res (Phila). 2016 Apr;9(4):265-74. doi: 10.1158/1940-6207.CAPR-15-0316. Epub 2016 Feb 9.
Adenoid cystic carcinomas (ACC) of the salivary glands are challenging to understand, treat, and cure. To better understand the genetic alterations underlying the pathogenesis of these tumors, we performed comprehensive genome analyses of 25 fresh-frozen tumors, including whole-genome sequencing and expression and pathway analyses. In addition to the well-described MYB-NFIB fusion that was found in 11 tumors (44%), we observed five different rearrangements involving the NFIB transcription factor gene in seven tumors (28%). Taken together, NFIB translocations occurred in 15 of 25 samples (60%, 95% CI, 41%-77%). In addition, mRNA expression analysis of 17 tumors revealed overexpression of NFIB in ACC tumors compared with normal tissues (P = 0.002). There was no difference in NFIB mRNA expression in tumors with NFIB fusions compared with those without. We also report somatic mutations of genes involved in the axonal guidance and Rho family signaling pathways. Finally, we confirm previously described alterations in genes related to chromatin regulation and Notch signaling. Our findings suggest a separate role for NFIB in ACC oncogenesis and highlight important signaling pathways for future functional characterization and potential therapeutic targeting.
涎腺腺样囊性癌(ACC)在理解、治疗和治愈方面都具有挑战性。为了更好地了解这些肿瘤发病机制背后的基因改变,我们对25个新鲜冷冻肿瘤进行了全面的基因组分析,包括全基因组测序、表达分析和通路分析。除了在11个肿瘤(44%)中发现的已被充分描述的MYB-NFIB融合外,我们在7个肿瘤(28%)中观察到涉及NFIB转录因子基因的5种不同重排。总体而言,25个样本中有15个(60%,95%置信区间,41%-77%)发生了NFIB易位。此外,对17个肿瘤的mRNA表达分析显示,与正常组织相比,ACC肿瘤中NFIB表达上调(P = 0.002)。有NFIB融合的肿瘤与没有NFIB融合的肿瘤在NFIB mRNA表达上没有差异。我们还报告了轴突导向和Rho家族信号通路相关基因的体细胞突变。最后,我们证实了先前描述的与染色质调控和Notch信号相关基因的改变。我们的研究结果表明NFIB在ACC肿瘤发生中具有独立作用,并突出了未来功能表征和潜在治疗靶点的重要信号通路。